Newswise — Vycor Medical, Inc. (VYCO.BB) (www.vycormedical.com ), a medical device company that designs, develops and markets next generation neurosurgery retraction devices, today announced its ViewSite Brain Access System (VBAS) medical retraction device continues to gain ground. This "BioTech Breakthrough" - with the potential to impact several hundreds of thousands of patients and throngs of surgeons and medical facilities worldwide - is among a pioneering new breed of cost-reducing surgical devices designed to enhance performance, quality of life and surgical results.
"Most are shocked to learn that neurosurgical retraction technology has not significantly changed in nearly a Century," said Heather N. Vinas, president of Vycor Medical, Inc. “Where other forms of diagnostic and operative procedures have evolved by leaps and bounds, this crucial area of surgery has remained virtually unchanged to the detriment of patients, physicians and surgical facilities, alike. Vycor has single-handedly changed all that with a NeuroTech advancement that's also fiscally sound."
Indeed, Vycor's ViewSite Brain Access System (VBAS), the first significant neurosurgery retraction device redesign in more than 80 years, offers less invasive way to access surgical locations and perform critical procedures with minimal damage to surrounding brain tissue, thus minimizing collateral trauma and accelerating post-operative recovery. Given the estimated 600,000 brain surgeries conducted annually around the globe, this is a very significant and sizeable problem that ViewSite is directly - and aggressively - addressing.
Vycor Medical is taking its VBAS global as evidenced by its array of international distributor partnerships. Neurosurgeons around the world are embracing ViewSite and physician testimonials abound. For one, Michael W. Weaver, M.D. Assistant Professor of Neurosurgery at Temple University, applauds this next-generation retraction device, noting, "The ViewSite Brain Access System provides a minimally traumatic surgical corridor to deep seated brain tumors, resulting in effective and efficient tumor removal with minimal morbidity. I have been extremely pleased with the results of the surgeries I have performed with the ViewSite.”
About Vycor Medical, Inc.With corporate headquarters in Bohemia, NY, Vycor Medical, Inc. (VYCO.BB) is a medical device company committed to making brain, spinal and other surgical procedures safer and more effective. The company’s flagship, Patent Pending ViewSite™ Surgical Access Systems represent an exciting new breed of retraction technology that holds the potential for speedier, safer and more economical brain, spinal and other surgeries and a quicker patient discharge. Vycor’s innovative medical instruments are designed to optimize neurosurgical site access, reduce patient risk, accelerate recovery, and add tangible value to the professional medical community. Vycor is ISO 13485:2003 compliant, has FDA 510(K) clearance for brain and spine surgeries, and CE marketing and HPB licensing in Canada. Learn more online at www.vycormedical.com.
Safe Harbor StatementInformation in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "forecast", "anticipate", "estimate", "project", "intend", "expect", "should", "believe", and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause Vycor Medical's actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in Vycor Medical’s filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to Vycor Medical herein are expressly qualified in their entirety by the abovementioned cautionary statement. Vycor Medical disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.
RSS